Skip to content
Commercial Robot

Senhance Surgical System

Asensus Surgical

Senhance Surgical System by Asensus Surgical

Description

Senhance was a laparoscopic robotic surgery system with separate arm carts and an open surgeon console, developed by TransEnterix (renamed Asensus Surgical in 2021, acquired by KARL STORZ in 2024). It received its first FDA 510(k) clearance in October 2017, but KARL STORZ announced in June 2026 that it is discontinuing the Senhance line as part of fully integrating Asensus.

commercialmedicalsurgerysurgeon-controlledrobotic-systemhapticshospitaldiscontinuedlegacy

Specifications

PriceNot disclosed
Release Date2017
Back to catalog